XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,491 | +3.6% | 1,683 | +16.8% | 0.00% | – |
| Q2 2023 | $55,478 | +50.8% | 1,441 | +40.2% | 0.00% | – |
| Q1 2023 | $36,792 | -38.9% | 1,028 | -32.6% | 0.00% | – |
| Q4 2022 | $60,170 | -100.0% | 1,526 | -69.2% | 0.00% | – |
| Q3 2022 | $178,912,000 | +114.3% | 4,956 | +80.6% | 0.00% | – |
| Q2 2022 | $83,472,000 | +104.7% | 2,744 | +105.7% | 0.00% | – |
| Q1 2022 | $40,780,000 | +1531.9% | 1,334 | +1567.5% | 0.00% | – |
| Q4 2021 | $2,499,000 | -67.4% | 80 | -84.1% | 0.00% | – |
| Q3 2021 | $7,671,000 | -15.9% | 502 | +2.4% | 0.00% | – |
| Q2 2021 | $9,124,000 | +122.6% | 490 | +114.0% | 0.00% | – |
| Q1 2021 | $4,099,000 | +289.6% | 229 | +141.1% | 0.00% | – |
| Q3 2020 | $1,052,000 | – | 95 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |